NLS Pharmaceutics

-$0.16 (-6.87%) Today
$0.00 (0.00%) As of 9:17 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLSP and other ETFs, options, and stocks.

About NLSP

NLS Pharmaceutics Ltd. engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder. The company was founded by Ronald Hafner and Alexander Zwyer in June 2015 and is headquartered in Stans, Switzerland.

CEO
Alexander Zwyer
Employees
6
Headquarters
Stans, Nidwalden
Founded
2015

NLSP Key Statistics

Market Cap
26.19M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
54.41K
High Today
$2.30
Low Today
$2.12
Open Price
$2.22
Volume
77.26K
52 Week High
$7.35
52 Week Low
$2.06

NLSP Earnings

Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Nov 25, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure